Published

Psychedelics for Psychiatric Disorders: Promise, Not Panacea

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Psychiatric Annals
Date: 2022-09-01
Source: OpenAlex
DOI: 10.3928/00485713-20220810-01
PubMed: Unavailable

Authors

Mitch Earleywine Zachary Herrmann

Watch author

Derived topics and classifications

psilocybin Depression Anxiety PTSD End-of-Life Distress Mechanism of Action Cancer Patients Treatment-Resistant Depression Toxicity Other

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Psychedelics for Psychiatric Disorders: Promise, Not Panacea2022-09-01

Related papers

Psilocybin may help cancer patients with depression and anxiety for yearsAccess Science · 2020-01-01 The Utility of Psilocybin in Managing Anxiety and Depression in Cancer PatientsBiochemistry and Molecular Biology Education · 2018-08-01 SPECIAL ISSUE: Do Biofeedback, Neurofeedback, and Neuromeditation Have a Role in Psychedelic-Assisted Therapies?Biofeedback · 2022-01-01 Psychedelics and mental health: reimagining care through science, insight, and compassion.Frontiers in pharmacology · 2025-01-01 LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders: a Randomized, Double-blind, Placebo-controlled Phase II StudyClinicalTrials.gov · 2021-12-22